Research Summary
Antivenom, also known as antivenin, venom antiserum, and antivenom immunoglobulin, is a medication made from antibodies that is used to treat certain venomous bites and stings. It is created by injecting small amounts of venom into animals to stimulate an immune response, and then harvesting and purifying the antibodies produced by the animal's immune system. When administered to a person who has been bitten or stung by an venomous animal, the antivenom neutralizes the toxins in the venom and helps prevent or reverse the effects of envenomation. Antivenoms can be species-specific or broad-spectrum, and are often used in conjunction with other medical interventions to manage symptoms and prevent complications.
According to DIResearch's in-depth investigation and research, the global Antivenom market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Antivenom include CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Antivenom. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Antivenom market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Antivenom market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Antivenom industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Antivenom Include:
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Antivenom Product Segment Include:
Polyvalent antivenom
Monovalent antivenom
Antivenom Product Application Include:
Non-profit Institutions
Hospitals and Clinic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Antivenom Industry PESTEL Analysis
Chapter 3: Global Antivenom Industry Porter's Five Forces Analysis
Chapter 4: Global Antivenom Major Regional Market Size and Forecast Analysis
Chapter 5: Global Antivenom Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Antivenom Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Antivenom Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Antivenom Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Antivenom Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Antivenom Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Antivenom Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Antivenom Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Antivenom Market Overview 1.1 Product Definition and Statistical Scope 1.2 Antivenom Product by Type 1.2.1 Global Antivenom Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Polyvalent antivenom 1.2.3 Monovalent antivenom 1.3 Antivenom Product by Application 1.3.1 Global Antivenom Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Non-profit Institutions 1.3.3 Hospitals and Clinic 1.4 Global Antivenom Market Revenue Analysis (2019-2030) 1.5 Antivenom Market Development Status and Trends 1.5.1 Antivenom Industry Development Status Analysis 1.5.2 Antivenom Industry Development Trends Analysis 2 Antivenom Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Antivenom Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Antivenom Market Analysis by Regions 4.1 Antivenom Overall Market: 2023 VS 2024 VS 2030 4.2 Global Antivenom Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Antivenom Revenue and Market Share by Region (2019-2024) 4.2.2 Global Antivenom Revenue Forecast by Region (2025-2030) 5 Global Antivenom Market Size by Type and Application 5.1 Global Antivenom Market Size by Type 5.2 Global Antivenom Market Size by Application 6 North America 6.1 North America Antivenom Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Antivenom Market Size by Type 6.4 North America Antivenom Market Size by Application 6.5 North America Antivenom Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Antivenom Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Antivenom Market Size by Type 7.4 Europe Antivenom Market Size by Application 7.5 Europe Antivenom Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Antivenom Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Antivenom Market Size by Type 8.4 China Antivenom Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Antivenom Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Antivenom Market Size by Type 9.4 APAC (excl. China) Antivenom Market Size by Application 9.5 APAC (excl. China) Antivenom Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Antivenom Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Antivenom Market Size by Type 10.4 Latin America Antivenom Market Size by Application 10.5 Latin America Antivenom Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Antivenom Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Antivenom Market Size by Type 11.4 Middle East & Africa Antivenom Market Size by Application 11.5 Middle East & Africa Antivenom Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Antivenom Market Revenue by Key Manufacturers (2020-2024) 12.2 Antivenom Competitive Landscape Analysis and Market Dynamic 12.2.1 Antivenom Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 CSL 13.1.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 CSL Antivenom Product Portfolio 13.1.3 CSL Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Merck 13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Merck Antivenom Product Portfolio 13.2.3 Merck Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 BTG 13.3.1 BTG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 BTG Antivenom Product Portfolio 13.3.3 BTG Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Pfizer 13.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Pfizer Antivenom Product Portfolio 13.4.3 Pfizer Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Haffkine Bio-Pharmaceutical 13.5.1 Haffkine Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Haffkine Bio-Pharmaceutical Antivenom Product Portfolio 13.5.3 Haffkine Bio-Pharmaceutical Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Rare Disease Therapeutics 13.6.1 Rare Disease Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Rare Disease Therapeutics Antivenom Product Portfolio 13.6.3 Rare Disease Therapeutics Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Flynn Pharma 13.7.1 Flynn Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Flynn Pharma Antivenom Product Portfolio 13.7.3 Flynn Pharma Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Vins Bioproducts 13.8.1 Vins Bioproducts Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Vins Bioproducts Antivenom Product Portfolio 13.8.3 Vins Bioproducts Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Bharat Serums and Vaccines 13.9.1 Bharat Serums and Vaccines Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Bharat Serums and Vaccines Antivenom Product Portfolio 13.9.3 Bharat Serums and Vaccines Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Serum Biotech 13.10.1 Serum Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Serum Biotech Antivenom Product Portfolio 13.10.3 Serum Biotech Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 MicroPharm 13.11.1 MicroPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 MicroPharm Antivenom Product Portfolio 13.11.3 MicroPharm Antivenom Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Antivenom Industry Chain Analysis 14.2 Antivenom Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Antivenom Typical Downstream Customers 14.4 Antivenom Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support